YuCen Zhou
Biographic Data
| ID | 8915645 |
|---|---|
| NAME | YuCen Zhou |
| GIVEN NAMES | YuCen |
| FAMILY NAME | Zhou |
| SIGNATURE | ZHOU Y |
| AFFILIATIONS | Ministry of Education - Singapore |
| ORCID | 0009-0007-6075-1702 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Dabupi decoction mitigates fluorouracil-induced intestinal mucositis via farnesoid X receptor activation and dihydropyrimidine dehydrogenase upregulation
ETHNOPHARMACOLOGICAL RELEVANCE: 5-Fluorouracil (5-FU) is a widely utilized antimetabolite in colorectal cancer chemotherapy, primarily exerting its cytotoxic effects by irreversibly inhibiting thymidylate synthase (TS). This inhibition leads to a reduction in deoxythymidine monophosphate (dTMP), which disrupts DNA synthesis and repair. A major challenge in 5-FU treatment is the dose-limiting toxicity of chemotherapeutic-induced intestinal mucosit…
No prominent works on this page.
Dabupi decoction mitigates fluorouracil-induced intestinal mucositis via farnesoid X receptor activation and dihydropyrimidine dehydrogenase upregulation
ETHNOPHARMACOLOGICAL RELEVANCE: 5-Fluorouracil (5-FU) is a widely utilized antimetabolite in colorectal cancer chemotherapy, primarily exerting its cytotoxic effects by irreversibly inhibiting thymidylate synthase (TS). This inhibition leads to a reduction in deoxythymidine monophosphate (dTMP), which disrupts DNA synthesis and repair. A major challenge in 5-FU treatment is the dose-limiting toxicity of chemotherapeutic-induced intestinal mucosit…
Bile acid (1 work) · Colorectal Cancer Treatments and Studies (1 work) · Dihydropyrimidine dehydrogenase (1 work) · Downregulation and upregulation (1 work) · Effects of Radiation Exposure (1 work) · Enzyme (1 work) · Farnesoid X receptor (1 work) · Mucositis (1 work) · Oral health in cancer treatment (1 work) · Thymidylate synthase (1 work)